Twist Bioscience Corporation (TWST) Tops Q2 EPS by 15c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($1.13), $0.15 better than the analyst estimate of ($1.28). Revenue for the quarter came in at $48.1 million versus the consensus estimate of $45.25 million.

As of March 31, 2022, the company had $604.4 million in cash, cash equivalents and investments.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform